Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Amelia Licari, Riccardo Castagnoli, Maria Angela Tosca, Gianluigi Marseglia & Giorgio Ciprandi. (2019) Personalized therapies for the treatment of allergic rhinitis. Expert Review of Precision Medicine and Drug Development 4:5, pages 275-281.
Read now
Read now
Braeden Donaldson, Zabeen Lateef, Greg F. Walker, Sarah L. Young & Vernon K. Ward. (2018) Virus-like particle vaccines: immunology and formulation for clinical translation. Expert Review of Vaccines 17:9, pages 833-849.
Read now
Read now
Carlos Gamazo, Carmen D'Amelio, Gabriel Gastaminza, Marta Ferrer & Juan M. Irache. (2017) Adjuvants for allergy immunotherapeutics. Human Vaccines & Immunotherapeutics 13:10, pages 2416-2427.
Read now
Read now
Ludger Klimek, Carsten B. Schmidt-Weber, Matthias F. Kramer, Murray A. Skinner & Matthew D. Heath. (2017) Clinical use of adjuvants in allergen-immunotherapy. Expert Review of Clinical Immunology 13:6, pages 599-610.
Read now
Read now
Amelia Licari, Riccardo Castagnoli, Chiara Bottino, Alessia Marseglia, GianLuigi Marseglia & Giorgio Ciprandi. (2016) Emerging drugs for the treatment of perennial allergic rhinitis. Expert Opinion on Emerging Drugs 21:1, pages 57-67.
Read now
Read now
Articles from other publishers (20)
Phornsiri PechsrichuangSupannika NamwongnaoAlain Jacquet. (2021) Bioengineering of Virus-like Particles for the Prevention or Treatment of Allergic Diseases. Allergy, Asthma & Immunology Research 13:1, pages 23.
Crossref
Crossref
Abida Zahirović, Jernej Luzar, Peter Molek, Nika Kruljec & Mojca Lunder. (2019) Bee Venom Immunotherapy: Current Status and Future Directions. Clinical Reviews in Allergy & Immunology 58:3, pages 326-341.
Crossref
Crossref
Elisa S. Roesti, Christina N. Boyle, Daniel T. Zeman, Marcos Sande-Melon, Federico Storni, Gustavo Cabral-Miranda, Alexander Knuth, Thomas A. Lutz, Monique Vogel & Martin F. Bachmann. (2020) Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus. Vaccines 8:1, pages 116.
Crossref
Crossref
Bernhard Kratzer, Sandra Hofer, Maja Zabel & Winfried F. Pickl. (2019) All the small things: How virus‐like particles and liposomes modulate allergic immune responses. European Journal of Immunology 50:1, pages 17-32.
Crossref
Crossref
Oliver Pfaar, Hongfei Lou, Yuan Zhang, Ludger Klimek & Luo Zhang. (2018) Recent developments and highlights in allergen immunotherapy. Allergy 73:12, pages 2274-2289.
Crossref
Crossref
L. Klimek, G. Senti, H. J. Hoffmann & T. Kündig. (2018) What Do We Really Know About Intralymphatic Immunotherapy?. Current Treatment Options in Allergy 5:4, pages 415-423.
Crossref
Crossref
Martina Anzaghe, Stefan Schülke & Stephan Scheurer. (2018) Virus-Like Particles as Carrier Systems to Enhance Immunomodulation in Allergen Immunotherapy. Current Allergy and Asthma Reports 18:12.
Crossref
Crossref
Abida Zahirović & Mojca Lunder. (2018) Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases. Frontiers in Microbiology 9.
Crossref
Crossref
Brittany E Givens, Sean M Geary & Aliasger K Salem. (2018) Nanoparticle-based CpG-oligonucleotide therapy for treating allergic asthma. Immunotherapy 10:7, pages 595-604.
Crossref
Crossref
Zejun Wang, Wenhan Liu, Jiye Shi, Nan Chen & Chunhai Fan. (2018) Nanoscale delivery systems for cancer immunotherapy. Materials Horizons 5:3, pages 344-362.
Crossref
Crossref
Wenhan Liu, Zejun Wang, Yao Luo & Nan Chen. (2017) Application of Nanocomposites in Cancer Immunotherapy. Nano LIFE 07:03n04, pages 1750008.
Crossref
Crossref
Andris Zeltins, Jonathan West, Franziska Zabel, Aadil El Turabi, Ina Balke, Stefanie Haas, Melanie Maudrich, Federico Storni, Paul Engeroff, Gary T. Jennings, Abhay Kotecha, David I Stuart, John Foerster & Martin F. Bachmann. (2017) Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy. npj Vaccines 2:1.
Crossref
Crossref
Douglas J. DeBoer. 2017. Advances in Veterinary Dermatology. Advances in Veterinary Dermatology
26
31
.
Douglas J. DeBoer. (2017) The future of immunotherapy for canine atopic dermatitis: a review. Veterinary Dermatology 28:1, pages 25-e6.
Crossref
Crossref
Celso Eduardo Olivier. (2017) The use of Allergoids and Adjuvants in Allergen Immunotherapy. Archives of Asthma, Allergy and Immunology 1:1, pages 040-060.
Crossref
Crossref
Amelia Licari, Gianluigi Marseglia & Giorgio Ciprandi. (2016) New Pharmacologic Strategies for Allergic Rhinitis. Current Treatment Options in Allergy 3:4, pages 495-505.
Crossref
Crossref
B. Corthésy, A. Lassus, J. Terrettaz, F. Tranquart & G. Bioley. (2016) Efficacy of a therapeutic treatment using gas-filled microbubble-associated phospholipase A2 in a mouse model of honeybee venom allergy. Allergy 71:7, pages 957-966.
Crossref
Crossref
Paul Pumpens, Regina Renhofa, Andris Dishlers, Tatjana Kozlovska, Velta Ose, Peter Pushko, Kaspars Tars, Elmars Grens & Martin F. Bachmann. (2016) The True Story and Advantages of RNA Phage Capsids as Nanotools. Intervirology 59:2, pages 74-110.
Crossref
Crossref
Marie Ballester, Laura Jeanbart, Alexandre de Titta, Chiara Nembrini, Benjamin J. Marsland, Jeffrey A. Hubbell & Melody A. Swartz. (2015) Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice. Scientific Reports 5:1.
Crossref
Crossref
O. Palomares, R. Crameri & C. Rhyner. (2014) The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases. Allergy 69:12, pages 1588-1601.
Crossref
Crossref